Enovis ENOV
NYSE ENOV
$26.17 -0.33 (-1.25%)
As of: Aug 20, 2026 · 3:59 PM EDT

Enovis (ENOV) Gains from Investment Securities (2024 - 2025)

Enovis (ENOV) posted quarterly Gains from Investment Securities of $1.8 million for Q4 2025, up 1900.0% year-over-year from $90000.0 in Q4 2024, and little changed quarter-over-quarter from $1.8 million in Q3 2025.

Enovis (ENOV) Gains from Investment Securities (2024 - 2025) Analysis & Trends

Enovis (ENOV) has reported Gains from Investment Securities for 2 consecutive years, with $1.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Gains from Investment Securities rose 1900.0% year-over-year to $1.8 million; the TTM figure through Apr 2026 stood at $3.6 million (up 111.25% YoY), while the FY2025 annual figure was $1.8 million, up 108.89% from the prior year.
  • Gains from Investment Securities held at $1.8 million in Q4 2025 per ENOV's latest filing, from $1.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $13.4 million in Q1 2024 and bottomed at -$33.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Enovis 1.50 Bn 1.48 Bn 359.25 Mn

Historic Data

Download Data
DateValue
Oct 3, 2025 1.80 Mn
Oct 3, 2025 1.80 Mn
Jul 4, 2025 1.80 Mn
Jul 4, 2025 1.80 Mn
Apr 4, 2025 1.79 Mn
Apr 4, 2025 1.79 Mn
Dec 31, 2024 -178,000.00
Dec 31, 2024 -178,000.00
Sep 27, 2024 -100,000.00
Sep 27, 2024 -100,000.00
Jun 28, 2024 -33.50 Mn
Jun 28, 2024 -33.50 Mn
Mar 29, 2024 13.40 Mn
Mar 29, 2024 13.40 Mn